The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...

MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

US FDA approves Regeneron’s gene therapy, Otarmeni for genetic hearing loss: Tarrytown, New York Regeneron Pharmaceuticals, Inc., a leadi ...

The FDA has approved Otarmeni, the first gene therapy for genetic hearing loss, through its National Priority Voucher program ...

The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...

Before a baby’s first babble, language development begins through exposure to voices, music, and everyday sounds. But what happens when that connection to sound is missing from the start? For ...

The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.

Consuming foods high in carotenoids appeared to be modestly linked to a reduced risk for pediatric hearing loss, according to a poster presented at the Pediatric Academic Societies (PAS) 2025 Meeting.

WASHINGTON (7News) — 7News On Your Side with a warning from doctors about childhood hearing loss. Dr. Brian Reilly – a pediatric Otolaryngologist and co-director of the cochlear implant team at ...

Hearing care for school children is poor at best, with many states lacking testing mandates, equipment not maintained, and a "gold standard" of testing developed in 1879 There are approximately ...